ACURASTEM INC
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.9Mattributed |
|---|---|
| Latest round | grant, $2.9M, 2023-08-01attributed |
| Founded | 2017 |
| Headquarters | MONROVIA, California, USA |
| Industry | bio |
| Stage | unknown |
| Website | acurastem.com |
AcuraStem develops treatments for neurodegenerative diseases like ALS and FTD. It serves patients suffering from these conditions. Its iNeuroRx platform uses patient-derived disease models instead of animal models to discover more effective treatments.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-08-01 | grant | $2.9M | undisclosed |
Detected tech stack
Apache HTTP Server 2.4.52, Magnific Popup, Ubuntu, reCAPTCHA, Google Analytics, Google Tag Manager, DoubleClick Floodlight, Concrete CMS, OWL Carousel, WordPress, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.9M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.9M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | acurastem.com, read 2026-05-05 |
| Description | self-reported | acurastem.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.